<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Worldwide clinical experience with ACE inhibitors : the role of quinapril, Marbella, Spain, June 10-11, 1989</dc:title>
  <dc:contributor>Parke-Davis. Division Warner-Lambert Company (Funder/Sponsor)</dc:contributor>
  <dc:contributor>Investigators' meeting (Marbella 1989-06-10)</dc:contributor>
  <dc:relation>Journal of cardiovascular pharmacology -- J. cardiovasc. pharmacol, CODEN JCPCDT, ISSN 0160-2446, Vol. 15, pp. S1-S61</dc:relation>
  <dc:date>1990</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Conference Proceedings</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>Lippincott</dc:publisher>
  <dc:publisher>Lippincott</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>67 p. ; dissem</dc:format>
  <dc:subject xml:lang="fr">Angiotensin converting enzyme</dc:subject>
  <dc:subject xml:lang="fr">Antihypertenseur</dc:subject>
  <dc:subject xml:lang="fr">Appareil circulatoire pathologie</dc:subject>
  <dc:subject xml:lang="fr">Chimiothérapie</dc:subject>
  <dc:subject xml:lang="fr">Congrès</dc:subject>
  <dc:subject xml:lang="fr">Hypertension artérielle</dc:subject>
  <dc:subject xml:lang="fr">Inhibiteur enzyme</dc:subject>
  <dc:subject xml:lang="fr">Pharmacologie</dc:subject>
  <dc:subject xml:lang="fr">Quinapril</dc:subject>
  <dc:subject xml:lang="fr">Tolérance</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="en">Angiotensin converting enzyme</dc:subject>
  <dc:subject xml:lang="en">Antihypertensive agent</dc:subject>
  <dc:subject xml:lang="en">Cardiovascular disease</dc:subject>
  <dc:subject xml:lang="en">Chemotherapy</dc:subject>
  <dc:subject xml:lang="en">Congress</dc:subject>
  <dc:subject xml:lang="en">Hypertension</dc:subject>
  <dc:subject xml:lang="en">Enzyme inhibitor</dc:subject>
  <dc:subject xml:lang="en">Pharmacology</dc:subject>
  <dc:subject xml:lang="en">Tolerance</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="es">Angiotensin converting enzyme</dc:subject>
  <dc:subject xml:lang="es">Antihipertensivo</dc:subject>
  <dc:subject xml:lang="es">Aparato circulatorio patología</dc:subject>
  <dc:subject xml:lang="es">Quimioterapia</dc:subject>
  <dc:subject xml:lang="es">Congreso</dc:subject>
  <dc:subject xml:lang="es">Hipertensión arterial</dc:subject>
  <dc:subject xml:lang="es">Inhibidor enzima</dc:subject>
  <dc:subject xml:lang="es">Farmacología</dc:subject>
  <dc:subject xml:lang="es">Tolerancia</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject>002B02F05: Antihypertenseurs / Antihypertensive agents</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 6893150</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>